Answers are grounded in this paper and cite their sources.
The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.
No takes yet. Share an insight, caveat, or question.
Courtney et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: